The much-anticipated rollout of the shorter regimen to treat drug-resistant tuberculosis (TB) has failed to make inroads leaving patients stranded across the country. Having started in March last year, only about 70 patients have received treatment – which is only being administered in four provinces. The new oral regimen can treat drug-resistant TB within a period of six months, instead of the usual 18 months. Read Here.
top of page
Recent Posts
See AllThis report marks the midway point of the 1/4/6×24 Campaign, which calls for the universal implementation of the best available TB regimens — as little as one month or once weekly for TB prevention, f
60
Their annual review provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB). View the full
90
The Indonesia AIDS Coalition (IAC) and Indonesia for Global Justice (IGJ) have filed a patent opposition for the Tuberculosis (TB) drug Bedaquiline with dispersible tablet formulations (hereinafter, i
400
bottom of page